Barclays PLC raised its stake in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 446.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 96,194 shares of the company's stock after acquiring an additional 78,583 shares during the period. Barclays PLC owned 0.21% of Avanos Medical worth $2,311,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in the stock. The Manufacturers Life Insurance Company raised its stake in shares of Avanos Medical by 3.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company's stock worth $341,000 after buying an additional 590 shares in the last quarter. KBC Group NV lifted its holdings in Avanos Medical by 63.0% in the 3rd quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after acquiring an additional 1,095 shares during the last quarter. New York State Teachers Retirement System boosted its position in shares of Avanos Medical by 2.0% during the 3rd quarter. New York State Teachers Retirement System now owns 72,294 shares of the company's stock valued at $1,737,000 after purchasing an additional 1,388 shares in the last quarter. Quarry LP acquired a new position in shares of Avanos Medical in the 3rd quarter worth approximately $42,000. Finally, Foundry Partners LLC raised its holdings in shares of Avanos Medical by 1.1% in the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company's stock worth $3,918,000 after purchasing an additional 1,800 shares in the last quarter. 95.17% of the stock is owned by institutional investors.
Avanos Medical Stock Up 0.9 %
NYSE:AVNS traded up $0.14 during trading hours on Thursday, hitting $16.16. 254,008 shares of the company's stock traded hands, compared to its average volume of 253,414. The stock's fifty day moving average price is $19.29 and its two-hundred day moving average price is $21.23. The firm has a market cap of $742.67 million, a P/E ratio of 47.53 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. Avanos Medical, Inc. has a twelve month low of $15.85 and a twelve month high of $25.36.
Wall Street Analyst Weigh In
Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.
Get Our Latest Analysis on Avanos Medical
Avanos Medical Profile
(
Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
